Brevibacterium paucivorans is an exceptionally rare bacterium known to cause human bloodstream infections. Its epidemiology is characterized by extreme scarcity in reported cases. As of the available literature, only one documented case of B. paucivorans bacteremia has been reported, dating back to 2001 in Taiwan.
This isolated instance occurred in a 94-year-old woman with underlying health conditions, including chronic heart failure and diabetes mellitus, who had a history of recurrent hospitalizations and exposure to broad-spectrum antibiotics. The rapid onset of high fever and positive blood cultures within 24 hours of admission marked the clinical presentation.
The infection was effectively treated with a combination of vancomycin and cefepime. Despite the limited data, the suspected sources of infection were speculated to be contaminated catheters or skin flora. B.paucivorans has not been linked to any outbreaks or endemic occurrences. It is primarily considered a low-virulence organism that seldom causes disease in humans, especially those with intact immune systems.
Although the mortality rate associated with B. paucivorans bacteremia is relatively low, at 6.7%, it can lead to complications such as septic shock. This bacterium’s precise prevalence and distribution in the environment or among animals still need to be better understood due to its infrequent isolation in clinical settings.
Interestingly, B. paucivorans shares genetic similarities with Brevibacterium casei, a bacterium commonly found in cheese and dairy products. This relationship highlights potential connections between environmental reservoirs and human infections, although further research is needed to elucidate these associations.
This bacterium features a club-shaped or slightly curved morphology, occasionally presenting coccal forms. Its cell dimensions typically range from 0.5 to 0.8 μm in width and 1.0 to 2.5 μm in length.
The cell wall of B. paucivorans comprises meso-diaminopimelic acid, arabinose, and galactose. This unique cell wall composition distinguishes it from other bacterial species and contributes to its biological properties.
Brevibacterium paucivorans exhibit a complex antigenic profile characterized by both conformational and linear antigenic determinants. Conformational epitopes, formed by non-contiguous sections of the antigen’s amino acid sequence, coexist with linear epitopes composed of continuous amino acid sequences.
Within B. paucivorans, various proteins play essential roles in its cell wall structure, metabolic processes, antigen presentation, and virulence mechanisms. Some notable examples of these proteins include meso-diaminopimelic acid, arabinose, galactose, major histocompatibility complex class I (MHC-I), major histocompatibility complex class II (MHC-II), proteases, and lipases.
The type strain of B. paucivorans, designated as CF62T (= DSM 13657T), exhibits a DNA G+C content of 55.8 mol%. This molecular characteristic serves as a taxonomic marker, aiding in identifying and differentiating this rare bacterium.
The pathogenesis of B. paucivorans in humans remains challenging due to its rarity as a causative agent of bloodstream infections. Limited clinical cases suggest that this bacterium may possess certain pathogenic mechanisms. One potential avenue is its ability to adhere to and colonize medical devices such as catheters or the skin, making them potential sources of infection.
This adherence capability could facilitate the establishment of the bacterium within the host.B. paucivorans has demonstrated the ability to cause bacteremia even in immunocompetent individuals, suggesting a possible ability to evade the host immune system. The precise mechanisms employed by the bacterium to circumvent immune defenses remain poorly understood, warranting further investigation.
Another aspect to consider is antibiotic resistance. Brevibacterium paucivorans has exhibited resistance to antibiotics such as penicillin, ampicillin, and erythromycin. This resistance profile implies the presence of mechanisms that enable the bacterium to withstand specific antimicrobial agents. It is conceivable that B. paucivorans possesses as-yet-unidentified virulence factors, including components of its cell wall or specific enzymes that contribute to its pathogenicity.
Human host defenses against Brevibacterium paucivorans remain incompletely understood, but several potential factors have been identified.
Innate Immunity: The skin and mucous membranes serve as critical physical barriers, aiming to thwart the entry of Brevibacterium paucivorans. The normal flora inhabiting the skin and other anatomical sites may compete with this organism for essential nutrients and attachment sites. The complement system, composed of various proteins, phagocytes, and natural killer cells, could play roles in eliminating these bacteria if they breach the body’s defenses and invade the bloodstream or tissues.
Adaptive Immunity:Brevibacterium paucivorans antigens may trigger adaptive immune responses within the host. Antibodies generated in response to these antigens may enhance the opsonization and phagocytosis of the bacteria. Furthermore, T cells can recognize Brevibacterium paucivorans, potentially producing cytokines that amplify the inflammatory response and activate macrophages.
Brevibacterium paucivorans is uncommon, and it rarely causes bacteremia, primarily affecting immunocompetent individuals. This bacterial infection can present with various clinical manifestations, often including a sudden onset of high fever.
Patients may also experience a significant decrease in oral intake and appetite loss, attributed to the systemic response to the infection.Furthermore, in severe cases, B. paucivorans bacteremia can progress to sepsis, a potentially life-threatening condition characterized by widespread inflammation and organ dysfunction.
Diagnosing B. paucivorans infections can be challenging due to its rarity and the potential for confusion with other coryneform bacteria or staphylococci. Several diagnostic methods are available to identify this bacterium:
Blood Cultures: Blood cultures are the primary method for detecting B. paucivorans in the bloodstream. However, this bacterium may exhibit slow growth and morphological characteristics that resemble other microorganisms. Therefore, careful observation and interpretation of blood culture results are essential.
Gram Staining: A simple and rapid initial test involves using a Gram stain to observe the morphology of the bacterium. B. paucivorans typically appear as gram-positive, club-shaped, slightly curved rods, with the possibility of coccal forms. However, this test lacks specificity and cannot distinguish B. paucivorans from similar bacteria reliably.
Matrix-Assisted Laser Ionization/Desorption Time-of-Flight Mass Spectrometry: MALDI-TOF MS is a modern and accurate diagnostic tool that identifies the bacterium based on its unique protein profile. Brevibacterium paucivorans can be identified by MALDI-TOF MS if it achieves a score value of 2.36 or higher. However, the availability and standardization of this test may vary among laboratories.
16S Ribosomal RNA Analysis: Molecular testing using 16S ribosomal RNA gene sequencing is a highly specific method for identifying B. paucivorans by its genetic sequence. It exhibits a high degree of homology (99.5%) with Brevibacterium casei. Nevertheless, this test can be costly, time-consuming, and require specialized equipment and expertise.
Individuals should take precautions to minimize exposure to potentially contaminated catheters or compromised skin, as these are recognized as potential sources of infection.
In healthcare settings and beyond, maintaining sanitation and stringent hygiene practices are crucial to prevent the transmission of Brevibacterium paucivorans and other coryneform organisms. This includes rigorous hand hygiene, proper disinfection procedures, and adherence to infection control protocols to minimize the risk of infection.
Brevibacterium paucivorans is an exceptionally rare bacterium known to cause human bloodstream infections. Its epidemiology is characterized by extreme scarcity in reported cases. As of the available literature, only one documented case of B. paucivorans bacteremia has been reported, dating back to 2001 in Taiwan.
This isolated instance occurred in a 94-year-old woman with underlying health conditions, including chronic heart failure and diabetes mellitus, who had a history of recurrent hospitalizations and exposure to broad-spectrum antibiotics. The rapid onset of high fever and positive blood cultures within 24 hours of admission marked the clinical presentation.
The infection was effectively treated with a combination of vancomycin and cefepime. Despite the limited data, the suspected sources of infection were speculated to be contaminated catheters or skin flora. B.paucivorans has not been linked to any outbreaks or endemic occurrences. It is primarily considered a low-virulence organism that seldom causes disease in humans, especially those with intact immune systems.
Although the mortality rate associated with B. paucivorans bacteremia is relatively low, at 6.7%, it can lead to complications such as septic shock. This bacterium’s precise prevalence and distribution in the environment or among animals still need to be better understood due to its infrequent isolation in clinical settings.
Interestingly, B. paucivorans shares genetic similarities with Brevibacterium casei, a bacterium commonly found in cheese and dairy products. This relationship highlights potential connections between environmental reservoirs and human infections, although further research is needed to elucidate these associations.
This bacterium features a club-shaped or slightly curved morphology, occasionally presenting coccal forms. Its cell dimensions typically range from 0.5 to 0.8 μm in width and 1.0 to 2.5 μm in length.
The cell wall of B. paucivorans comprises meso-diaminopimelic acid, arabinose, and galactose. This unique cell wall composition distinguishes it from other bacterial species and contributes to its biological properties.
Brevibacterium paucivorans exhibit a complex antigenic profile characterized by both conformational and linear antigenic determinants. Conformational epitopes, formed by non-contiguous sections of the antigen’s amino acid sequence, coexist with linear epitopes composed of continuous amino acid sequences.
Within B. paucivorans, various proteins play essential roles in its cell wall structure, metabolic processes, antigen presentation, and virulence mechanisms. Some notable examples of these proteins include meso-diaminopimelic acid, arabinose, galactose, major histocompatibility complex class I (MHC-I), major histocompatibility complex class II (MHC-II), proteases, and lipases.
The type strain of B. paucivorans, designated as CF62T (= DSM 13657T), exhibits a DNA G+C content of 55.8 mol%. This molecular characteristic serves as a taxonomic marker, aiding in identifying and differentiating this rare bacterium.
The pathogenesis of B. paucivorans in humans remains challenging due to its rarity as a causative agent of bloodstream infections. Limited clinical cases suggest that this bacterium may possess certain pathogenic mechanisms. One potential avenue is its ability to adhere to and colonize medical devices such as catheters or the skin, making them potential sources of infection.
This adherence capability could facilitate the establishment of the bacterium within the host.B. paucivorans has demonstrated the ability to cause bacteremia even in immunocompetent individuals, suggesting a possible ability to evade the host immune system. The precise mechanisms employed by the bacterium to circumvent immune defenses remain poorly understood, warranting further investigation.
Another aspect to consider is antibiotic resistance. Brevibacterium paucivorans has exhibited resistance to antibiotics such as penicillin, ampicillin, and erythromycin. This resistance profile implies the presence of mechanisms that enable the bacterium to withstand specific antimicrobial agents. It is conceivable that B. paucivorans possesses as-yet-unidentified virulence factors, including components of its cell wall or specific enzymes that contribute to its pathogenicity.
Human host defenses against Brevibacterium paucivorans remain incompletely understood, but several potential factors have been identified.
Innate Immunity: The skin and mucous membranes serve as critical physical barriers, aiming to thwart the entry of Brevibacterium paucivorans. The normal flora inhabiting the skin and other anatomical sites may compete with this organism for essential nutrients and attachment sites. The complement system, composed of various proteins, phagocytes, and natural killer cells, could play roles in eliminating these bacteria if they breach the body’s defenses and invade the bloodstream or tissues.
Adaptive Immunity:Brevibacterium paucivorans antigens may trigger adaptive immune responses within the host. Antibodies generated in response to these antigens may enhance the opsonization and phagocytosis of the bacteria. Furthermore, T cells can recognize Brevibacterium paucivorans, potentially producing cytokines that amplify the inflammatory response and activate macrophages.
Brevibacterium paucivorans is uncommon, and it rarely causes bacteremia, primarily affecting immunocompetent individuals. This bacterial infection can present with various clinical manifestations, often including a sudden onset of high fever.
Patients may also experience a significant decrease in oral intake and appetite loss, attributed to the systemic response to the infection.Furthermore, in severe cases, B. paucivorans bacteremia can progress to sepsis, a potentially life-threatening condition characterized by widespread inflammation and organ dysfunction.
Diagnosing B. paucivorans infections can be challenging due to its rarity and the potential for confusion with other coryneform bacteria or staphylococci. Several diagnostic methods are available to identify this bacterium:
Blood Cultures: Blood cultures are the primary method for detecting B. paucivorans in the bloodstream. However, this bacterium may exhibit slow growth and morphological characteristics that resemble other microorganisms. Therefore, careful observation and interpretation of blood culture results are essential.
Gram Staining: A simple and rapid initial test involves using a Gram stain to observe the morphology of the bacterium. B. paucivorans typically appear as gram-positive, club-shaped, slightly curved rods, with the possibility of coccal forms. However, this test lacks specificity and cannot distinguish B. paucivorans from similar bacteria reliably.
Matrix-Assisted Laser Ionization/Desorption Time-of-Flight Mass Spectrometry: MALDI-TOF MS is a modern and accurate diagnostic tool that identifies the bacterium based on its unique protein profile. Brevibacterium paucivorans can be identified by MALDI-TOF MS if it achieves a score value of 2.36 or higher. However, the availability and standardization of this test may vary among laboratories.
16S Ribosomal RNA Analysis: Molecular testing using 16S ribosomal RNA gene sequencing is a highly specific method for identifying B. paucivorans by its genetic sequence. It exhibits a high degree of homology (99.5%) with Brevibacterium casei. Nevertheless, this test can be costly, time-consuming, and require specialized equipment and expertise.
Individuals should take precautions to minimize exposure to potentially contaminated catheters or compromised skin, as these are recognized as potential sources of infection.
In healthcare settings and beyond, maintaining sanitation and stringent hygiene practices are crucial to prevent the transmission of Brevibacterium paucivorans and other coryneform organisms. This includes rigorous hand hygiene, proper disinfection procedures, and adherence to infection control protocols to minimize the risk of infection.
Brevibacterium paucivorans is an exceptionally rare bacterium known to cause human bloodstream infections. Its epidemiology is characterized by extreme scarcity in reported cases. As of the available literature, only one documented case of B. paucivorans bacteremia has been reported, dating back to 2001 in Taiwan.
This isolated instance occurred in a 94-year-old woman with underlying health conditions, including chronic heart failure and diabetes mellitus, who had a history of recurrent hospitalizations and exposure to broad-spectrum antibiotics. The rapid onset of high fever and positive blood cultures within 24 hours of admission marked the clinical presentation.
The infection was effectively treated with a combination of vancomycin and cefepime. Despite the limited data, the suspected sources of infection were speculated to be contaminated catheters or skin flora. B.paucivorans has not been linked to any outbreaks or endemic occurrences. It is primarily considered a low-virulence organism that seldom causes disease in humans, especially those with intact immune systems.
Although the mortality rate associated with B. paucivorans bacteremia is relatively low, at 6.7%, it can lead to complications such as septic shock. This bacterium’s precise prevalence and distribution in the environment or among animals still need to be better understood due to its infrequent isolation in clinical settings.
Interestingly, B. paucivorans shares genetic similarities with Brevibacterium casei, a bacterium commonly found in cheese and dairy products. This relationship highlights potential connections between environmental reservoirs and human infections, although further research is needed to elucidate these associations.
This bacterium features a club-shaped or slightly curved morphology, occasionally presenting coccal forms. Its cell dimensions typically range from 0.5 to 0.8 μm in width and 1.0 to 2.5 μm in length.
The cell wall of B. paucivorans comprises meso-diaminopimelic acid, arabinose, and galactose. This unique cell wall composition distinguishes it from other bacterial species and contributes to its biological properties.
Brevibacterium paucivorans exhibit a complex antigenic profile characterized by both conformational and linear antigenic determinants. Conformational epitopes, formed by non-contiguous sections of the antigen’s amino acid sequence, coexist with linear epitopes composed of continuous amino acid sequences.
Within B. paucivorans, various proteins play essential roles in its cell wall structure, metabolic processes, antigen presentation, and virulence mechanisms. Some notable examples of these proteins include meso-diaminopimelic acid, arabinose, galactose, major histocompatibility complex class I (MHC-I), major histocompatibility complex class II (MHC-II), proteases, and lipases.
The type strain of B. paucivorans, designated as CF62T (= DSM 13657T), exhibits a DNA G+C content of 55.8 mol%. This molecular characteristic serves as a taxonomic marker, aiding in identifying and differentiating this rare bacterium.
The pathogenesis of B. paucivorans in humans remains challenging due to its rarity as a causative agent of bloodstream infections. Limited clinical cases suggest that this bacterium may possess certain pathogenic mechanisms. One potential avenue is its ability to adhere to and colonize medical devices such as catheters or the skin, making them potential sources of infection.
This adherence capability could facilitate the establishment of the bacterium within the host.B. paucivorans has demonstrated the ability to cause bacteremia even in immunocompetent individuals, suggesting a possible ability to evade the host immune system. The precise mechanisms employed by the bacterium to circumvent immune defenses remain poorly understood, warranting further investigation.
Another aspect to consider is antibiotic resistance. Brevibacterium paucivorans has exhibited resistance to antibiotics such as penicillin, ampicillin, and erythromycin. This resistance profile implies the presence of mechanisms that enable the bacterium to withstand specific antimicrobial agents. It is conceivable that B. paucivorans possesses as-yet-unidentified virulence factors, including components of its cell wall or specific enzymes that contribute to its pathogenicity.
Human host defenses against Brevibacterium paucivorans remain incompletely understood, but several potential factors have been identified.
Innate Immunity: The skin and mucous membranes serve as critical physical barriers, aiming to thwart the entry of Brevibacterium paucivorans. The normal flora inhabiting the skin and other anatomical sites may compete with this organism for essential nutrients and attachment sites. The complement system, composed of various proteins, phagocytes, and natural killer cells, could play roles in eliminating these bacteria if they breach the body’s defenses and invade the bloodstream or tissues.
Adaptive Immunity:Brevibacterium paucivorans antigens may trigger adaptive immune responses within the host. Antibodies generated in response to these antigens may enhance the opsonization and phagocytosis of the bacteria. Furthermore, T cells can recognize Brevibacterium paucivorans, potentially producing cytokines that amplify the inflammatory response and activate macrophages.
Brevibacterium paucivorans is uncommon, and it rarely causes bacteremia, primarily affecting immunocompetent individuals. This bacterial infection can present with various clinical manifestations, often including a sudden onset of high fever.
Patients may also experience a significant decrease in oral intake and appetite loss, attributed to the systemic response to the infection.Furthermore, in severe cases, B. paucivorans bacteremia can progress to sepsis, a potentially life-threatening condition characterized by widespread inflammation and organ dysfunction.
Diagnosing B. paucivorans infections can be challenging due to its rarity and the potential for confusion with other coryneform bacteria or staphylococci. Several diagnostic methods are available to identify this bacterium:
Blood Cultures: Blood cultures are the primary method for detecting B. paucivorans in the bloodstream. However, this bacterium may exhibit slow growth and morphological characteristics that resemble other microorganisms. Therefore, careful observation and interpretation of blood culture results are essential.
Gram Staining: A simple and rapid initial test involves using a Gram stain to observe the morphology of the bacterium. B. paucivorans typically appear as gram-positive, club-shaped, slightly curved rods, with the possibility of coccal forms. However, this test lacks specificity and cannot distinguish B. paucivorans from similar bacteria reliably.
Matrix-Assisted Laser Ionization/Desorption Time-of-Flight Mass Spectrometry: MALDI-TOF MS is a modern and accurate diagnostic tool that identifies the bacterium based on its unique protein profile. Brevibacterium paucivorans can be identified by MALDI-TOF MS if it achieves a score value of 2.36 or higher. However, the availability and standardization of this test may vary among laboratories.
16S Ribosomal RNA Analysis: Molecular testing using 16S ribosomal RNA gene sequencing is a highly specific method for identifying B. paucivorans by its genetic sequence. It exhibits a high degree of homology (99.5%) with Brevibacterium casei. Nevertheless, this test can be costly, time-consuming, and require specialized equipment and expertise.
Individuals should take precautions to minimize exposure to potentially contaminated catheters or compromised skin, as these are recognized as potential sources of infection.
In healthcare settings and beyond, maintaining sanitation and stringent hygiene practices are crucial to prevent the transmission of Brevibacterium paucivorans and other coryneform organisms. This includes rigorous hand hygiene, proper disinfection procedures, and adherence to infection control protocols to minimize the risk of infection.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
